CPAP APAP denied as not FDA-approved for this use by Blue Cross Blue Shield?

Blue Cross Blue Shield's specific coverage criteria for cpap apap are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why BCBS May Issue a Not-FDA-Approved Denial for CPAP/APAP

CPAP and APAP devices are FDA-cleared medical devices — they undergo FDA's 510(k) substantial-equivalence review process for Class II medical devices rather than the drug-approval pathway. A "not-FDA-approved" denial for PAP therapy almost always reflects either an administrative coding error (the wrong HCPCS code was billed) or a misapplication of the plan's drug-approval language to DME equipment. It can also arise when a specific device feature or accessory is billed in a way the plan did not recognize.

Because FDA clearance for PAP devices is well-established and publicly verifiable through the FDA's 510(k) database, this type of denial is highly appealable and often resolved at the internal-appeal stage once the correct regulatory documentation is submitted.

## Federal Appeal Rights

• ERISA §503 (self-funded employer plans): full-and-fair internal review with written denial rationale.
• ACA §2719 (fully insured plans): independent external review by an accredited IRO after internal exhaustion.
• External-review window: generally approximately four months from the internal-denial notice; confirm the exact deadline on your denial letter.
• Expedited review: if your health would be seriously jeopardized by waiting, request expedited processing.

## Concrete Appeal Process

1. Request the complete denial notice with the specific policy language invoked ("not FDA-approved" vs. "not FDA-cleared" language matters). 2. Pull the FDA 510(k) clearance record for your specific device from the FDA's publicly accessible 510(k) database (search by device name or manufacturer). 3. Confirm with your DME supplier that the correct HCPCS codes (E0601 for CPAP, E0562/E0601 variants for APAP) were billed. 4. Submit the internal appeal with the FDA clearance letter and corrected billing documentation. 5. If the internal appeal fails, escalate to external review under ACA §2719 or ERISA.

## Documentation to Gather

• FDA 510(k) clearance summary: the publicly available clearance document showing the specific device model is FDA-cleared for treating sleep-disordered breathing.
• Manufacturer product labeling: the device's FDA-cleared indications for use.
• Correct billing codes: a statement from the DME supplier confirming the HCPCS code used and, if incorrect, a corrected claim.
• Prescriber order: the treating physician's prescription specifying the device type and diagnosis.
• Diagnostic sleep study: confirming the underlying condition and the clinical basis for the prescription.
• Prescriber letter: addressing the specific "not approved" language in the denial and citing FDA clearance status.

## Criteria-Mapping Structure

Your appeal letter should directly refute the denial basis:

| Denial Claim | Rebuttal Evidence | |---|---| | Device is not FDA-approved | FDA 510(k) clearance number [from database] + clearance date | | Coverage policy not met | Prescriber letter + BCBS DME policy language | | Billing/coding issue (if applicable) | Corrected HCPCS code from DME supplier | | Clinical necessity | Sleep-study report + treating physician diagnosis |

Cite the specific FDA clearance number and date in the appeal letter. Reviewers and external IROs respond quickly when regulatory status is documented with primary-source precision.